3-(3',5'-Di-tert-butyl-4'-hydroxyphenyl)propionic acid
20170-32-5CC(C)(C)c1cc(CCC(=O)O)cc(C(C)(C)C)c1OWPMYUUITDBHVQZ-UHFFFAOYSA-Ndo not confuse with the phenothiazine phenosan
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 75.9% (104 of 137) of all reports.
Warning
H302 (19%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 137 reports by companies from 5 notifications to the ECHA C&L Inventory.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Drugs used to cause dilation of the blood vessels.
使用It is employed as an active pharmaceutical intermediate.
20170-32-5DTXSID2066561